Hemoglobin level and morbidity in non-transfusion-dependent thalassemia

Blood Cells, Molecules, and Diseases

Volumn 55, Issue 2, 2015, Pages 108-109

  Taher, Ali T ^a   Musallam, Khaled M ^a,b   Saliba, Antoine N ^a   Garziadei, Giovanna ^b   Cappellini, Maria Domenica ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FERRITIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MORBIDITY; NON TRANSFUSION DEPENDENT THALASSEMIA; PATHOGENESIS; PRIORITY JOURNAL; THALASSEMIA; METABOLISM;

HEMOGLOBINS; HUMANS; MORBIDITY; THALASSEMIA;

EID: 84933565541     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2015.05.011     Document Type: Article

References (5)

1. Musallam K.M., Rivella S., Vichinsky E., Rachmilewitz E.A. Non-transfusion-dependent thalassemias. Haematologica 2013, 98:833-844.
2. Taher A., Vichinsky E., Musallam K., Cappellini M.D., Viprakasit V. Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT) 2013, Thalassaemia International Federation, Nicosia, Cyprus. D. Weatherall (Ed.).
3. Musallam K.M., Cappellini M.D., Daar S., et al. Serum ferritin level and morbidity risk in transfusion-independent patients with beta-thalassemia intermedia: the ORIENT study. Haematologica 2014, 99:e218-e221.
4. Musallam K.M., Cappellini M.D., Taher A.T. Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with beta-thalassemia intermedia. Blood Cells Mol. Dis. 2013, 51:35-38.
5. Taher A.T., Musallam K.M., Karimi M., et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 2010, 115:1886-1892.